Thu, Jun 20, 2013, 2:12 AM EDT - U.S. Markets open in 7 hrs 18 mins
The following patents & patent applications are licensed from Advanced Cell Technology, Inc.
A BTX/ACTC merger would be nice!
Biotime needs ACTC IPS cell technology, personalized therapy CANNOT be done without this IP.
Sentiment: Strong Buy
Yes, ACTC and BTX are tight.